Literature DB >> 2164832

Treatment of screen detected ductal carcinoma in situ: a silver lining within a grey cloud?

I S Fentiman.   

Abstract

Entities:  

Mesh：

Year:  1990        PMID： 2164832      PMCID： PMC1971702          DOI： 10.1038/bjc.1990.179

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  10 in total

1.  Edinburgh trial of screening for breast cancer: mortality at seven years.

Authors:  M M Roberts; F E Alexander; T J Anderson; U Chetty; P T Donnan; P Forrest; W Hepburn; A Huggins; A E Kirkpatrick; J Lamb
Journal:  Lancet       Date:  1990-02-03       Impact factor: 79.321

2.  Neu-protein overexpression in breast cancer. Association with comedo-type ductal carcinoma in situ and limited prognostic value in stage II breast cancer.

Authors:  M J van de Vijver; J L Peterse; W J Mooi; P Wisman; J Lomans; O Dalesio; R Nusse
Journal:  N Engl J Med       Date:  1988-11-10       Impact factor: 91.245

Review 3.  In-situ breast cancer: the EORTC consensus meeting.

Authors:  J A van Dongen; I S Fentiman; J R Harris; R Holland; J L Peterse; B Salvadori; H J Stewart
Journal:  Lancet       Date:  1989-07-01       Impact factor: 79.321

4.  Comparative features of ductal carcinoma in situ and infiltrating ductal carcinoma of the breast on fine-needle aspiration biopsy.

Authors:  H H Wang; B S Ducatman; D Eick
Journal:  Am J Clin Pathol       Date:  1989-12       Impact factor: 2.493

5.  Tamoxifen and contralateral breast cancer.

Authors:  J Cuzick; M Baum
Journal:  Lancet       Date:  1985-08-03       Impact factor: 79.321

6.  Ten- to fourteen-year effect of screening on breast cancer mortality.

Authors:  S Shapiro; W Venet; P Strax; L Venet; R Roeser
Journal:  J Natl Cancer Inst       Date:  1982-08       Impact factor: 13.506

7.  Mammographically detected duct carcinoma in situ. Frequency of local recurrence following tylectomy and prognostic effect of nuclear grade on local recurrence.

Authors:  M D Lagios; F R Margolin; P R Westdahl; M R Rose
Journal:  Cancer       Date:  1989-02-15       Impact factor: 6.860

8.  Tamoxifen and benign breast problems.

Authors:  I S Fentiman; T J Powles
Journal:  Lancet       Date:  1987-11-07       Impact factor: 79.321

9.  Reduction in mortality from breast cancer after mass screening with mammography. Randomised trial from the Breast Cancer Screening Working Group of the Swedish National Board of Health and Welfare.

Authors:  L Tabár; C J Fagerberg; A Gad; L Baldetorp; L H Holmberg; O Gröntoft; U Ljungquist; B Lundström; J C Månson; G Eklund
Journal:  Lancet       Date:  1985-04-13       Impact factor: 79.321

Review 10.  Overview of randomized trials of postoperative adjuvant radiotherapy in breast cancer.

Authors:  J Cuzick; H Stewart; R Peto; M Baum; B Fisher; H Host; J P Lythgoe; G Ribeiro; H Scheurlen; A Wallgren
Journal:  Cancer Treat Rep       Date:  1987-01
  10 in total
  3 in total

1.  Ductal carcinoma in situ.

Authors:  I S Fentiman
Journal:  BMJ       Date:  1992-05-16

2.  Immunohistochemical localisation of pS2 protein in ductal carcinoma in situ and benign lesions of the breast.

Authors:  Y A Luqmani; T Campbell; S Soomro; S Shousha; M C Rio; R C Coombes
Journal:  Br J Cancer       Date:  1993-04       Impact factor: 7.640

3.  Oestrogen receptor expression in ductal carcinoma in situ of the breast: relationship to flow cytometric analysis of DNA and expression of the c-erbB-2 oncoprotein.

Authors:  D N Poller; D R Snead; E C Roberts; M Galea; J A Bell; A Gilmour; C W Elston; R W Blamey; I O Ellis
Journal:  Br J Cancer       Date:  1993-07       Impact factor: 7.640
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.